These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 23563651)

  • 21. Dissecting the role of the S1P/S1PR axis in health and disease.
    Aarthi JJ; Darendeliler MA; Pushparaj PN
    J Dent Res; 2011 Jul; 90(7):841-54. PubMed ID: 21248363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of small-molecule inhibitors of sphingosine-1-phosphate signaling.
    Edmonds Y; Milstien S; Spiegel S
    Pharmacol Ther; 2011 Dec; 132(3):352-60. PubMed ID: 21906625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of macrophage function by sphingosine-1-phosphate.
    Weigert A; Weis N; Brüne B
    Immunobiology; 2009; 214(9-10):748-60. PubMed ID: 19625101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer.
    Ohotski J; Edwards J; Elsberger B; Watson C; Orange C; Mallon E; Pyne S; Pyne NJ
    Int J Cancer; 2013 Feb; 132(3):605-16. PubMed ID: 22733311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translational aspects of sphingosine 1-phosphate biology.
    Pyne S; Pyne NJ
    Trends Mol Med; 2011 Aug; 17(8):463-72. PubMed ID: 21514226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors.
    Waeber C; Blondeau N; Salomone S
    Drug News Perspect; 2004; 17(6):365-82. PubMed ID: 15334188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting sphingosine-1-phosphate signaling in lung diseases.
    Ebenezer DL; Fu P; Natarajan V
    Pharmacol Ther; 2016 Dec; 168():143-157. PubMed ID: 27621206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy?
    Dai L; Xia P; Di W
    Cancer Invest; 2014 Mar; 32(3):71-80. PubMed ID: 24499107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
    Huwiler A; Pfeilschifter J
    Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The drug development based on sphingosine-1-phosphate signaling pathway].
    Bai J; Hu JP
    Yao Xue Xue Bao; 2016 Dec; 51(12):1822-8. PubMed ID: 29908533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingosine-1-phosphate metabolism: A structural perspective.
    Pulkoski-Gross MJ; Donaldson JC; Obeid LM
    Crit Rev Biochem Mol Biol; 2015; 50(4):298-313. PubMed ID: 25923252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors.
    Pyne S; Pyne N
    Pharmacol Ther; 2000 Nov; 88(2):115-31. PubMed ID: 11150592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation.
    Hirata N; Yamada S; Shoda T; Kurihara M; Sekino Y; Kanda Y
    Nat Commun; 2014 Sep; 5():4806. PubMed ID: 25254944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence.
    Uranbileg B; Ikeda H; Kurano M; Enooku K; Sato M; Saigusa D; Aoki J; Ishizawa T; Hasegawa K; Kokudo N; Yatomi Y
    PLoS One; 2016; 11(2):e0149462. PubMed ID: 26886371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes.
    Ito S; Iwaki S; Koike K; Yuda Y; Nagasaki A; Ohkawa R; Yatomi Y; Furumoto T; Tsutsui H; Sobel BE; Fujii S
    Coron Artery Dis; 2013 Dec; 24(8):642-50. PubMed ID: 24212262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingosine kinase inhibitors: A patent review.
    Cao M; Ji C; Zhou Y; Huang W; Ni W; Tong X; Wei JF
    Int J Mol Med; 2018 May; 41(5):2450-2460. PubMed ID: 29484372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingosine 1-phosphate in renal diseases.
    Koch A; Pfeilschifter J; Huwiler A
    Cell Physiol Biochem; 2013; 31(6):745-60. PubMed ID: 23736205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting sphingosine-1-phosphate receptors in cancer.
    Watters RJ; Wang HG; Sung SS; Loughran TP; Liu X
    Anticancer Agents Med Chem; 2011 Nov; 11(9):810-7. PubMed ID: 21707490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2.
    Patmanathan SN; Johnson SP; Lai SL; Panja Bernam S; Lopes V; Wei W; Ibrahim MH; Torta F; Narayanaswamy P; Wenk MR; Herr DR; Murray PG; Yap LF; Paterson IC
    Sci Rep; 2016 May; 6():25650. PubMed ID: 27160553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
    Wang X; Sun Y; Peng X; Naqvi SMAS; Yang Y; Zhang J; Chen M; Chen Y; Chen H; Yan H; Wei G; Hong P; Lu Y
    Cancer Control; 2020; 27(1):1073274820976664. PubMed ID: 33317322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.